Driving precision oncology with chemagic technology

Despite its great value as a biomarker, extracting and purifying circulating free DNA (cfDNA) has traditionally posed challenges due to its low concentration and high level of fragmentation within the bloodstream. Revvity’s chemagic™ technology promises to offer a robust solution to address these challenges. Leveraging M-PVA magnetic bead technology to extract cfDNA from large plasma volumes, the DNA extraction and purification platform is designed to maximize yield and purity. When combined with advanced quantification technology such as Droplet Digital™ PCR (ddPCR), the workflow provides precision and repeatability in early cancer biomarker research.

In this case study, Revvity explores how chemagic DNA extraction and purification technology is helping to optimize results.